triamcinolone has been researched along with anecortave acetate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, AJ; Offermann, I | 1 |
1 review(s) available for triamcinolone and anecortave acetate
| Article | Year |
|---|---|
[Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
Topics: Alprostadil; Angiogenesis Inhibitors; Antioxidants; Choroidal Neovascularization; Clinical Trials as Topic; Combined Modality Therapy; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Triamcinolone; Vascular Endothelial Growth Factor A | 2008 |
2 other study(ies) available for triamcinolone and anecortave acetate
| Article | Year |
|---|---|
[Comments on current therapeutic possibilities for neovascular age-related macula degeneration].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Germany; Glucocorticoids; Humans; Laser Coagulation; Macular Degeneration; Photochemotherapy; Porphyrins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnadienediols; Ranibizumab; Triamcinolone; Verteporfin | 2006 |
Macular degeneration. Advances in treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Glucocorticoids; Humans; Light Coagulation; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Triamcinolone | 2006 |